192 related articles for article (PubMed ID: 31813263)
1. Growing consumption of antibiotics and epidemiology of Clostridioides difficile infections in Poland: A need to develop new solutions.
Jachowicz E; Pobiega M; Różańska A; Wójkowska-Mach J
Acta Microbiol Immunol Hung; 2020 Jun; 67(2):79-86. PubMed ID: 31813263
[TBL] [Abstract][Full Text] [Related]
2. Toxic megacolon complicating a Clostridium difficile infection in a pregnant woman.
Candiotto A; Pascoli I; Gritti A; Busato E; Dal Pozzo G
J Med Microbiol; 2010 Jan; 59(Pt 1):124-126. PubMed ID: 19745034
[TBL] [Abstract][Full Text] [Related]
3. [Clostridium difficile infection : What is currently available for treatment?].
Stallmach A
Internist (Berl); 2016 Dec; 57(12):1182-1190. PubMed ID: 27796474
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection: new developments in epidemiology and pathogenesis.
Rupnik M; Wilcox MH; Gerding DN
Nat Rev Microbiol; 2009 Jul; 7(7):526-36. PubMed ID: 19528959
[TBL] [Abstract][Full Text] [Related]
5. NAP1 strain type predicts outcomes from Clostridium difficile infection.
See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
[TBL] [Abstract][Full Text] [Related]
6. Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.
Mathur H; O'Connor PM; Hill C; Cotter PD; Ross RP
Antimicrob Agents Chemother; 2013 Jun; 57(6):2882-6. PubMed ID: 23571539
[TBL] [Abstract][Full Text] [Related]
7. Molecular Epidemiology of Clostridioides difficile Infections in Children.
Perumalsamy S; Riley TV
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S34-S40. PubMed ID: 34791401
[TBL] [Abstract][Full Text] [Related]
8. Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection.
Rea MC; Alemayehu D; Ross RP; Hill C
J Med Microbiol; 2013 Sep; 62(Pt 9):1369-1378. PubMed ID: 23699066
[TBL] [Abstract][Full Text] [Related]
9. [Clostridium difficile infection in children--experience of clinical centre in Bydgoszcz].
Duleba K; Smukalska E; Pawłowska M
Przegl Epidemiol; 2012; 66(1):67-71. PubMed ID: 22708301
[TBL] [Abstract][Full Text] [Related]
10. A review of the economics of treating Clostridium difficile infection.
Mergenhagen KA; Wojciechowski AL; Paladino JA
Pharmacoeconomics; 2014 Jul; 32(7):639-50. PubMed ID: 24807468
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile Infection.
Shin JH; Chaves-Olarte E; Warren CA
Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337475
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Clostridium difficile infection: results of a hospital-based study in Krakow, Poland.
Czepiel J; Kędzierska J; Biesiada G; Birczyńska M; Perucki W; Nowak P; Garlicki A
Epidemiol Infect; 2015 Nov; 143(15):3235-43. PubMed ID: 25858553
[TBL] [Abstract][Full Text] [Related]
13. Relationship between antibiotic consumption and Clostridium difficile-associated diarrhea: an epidemiological note.
Kaier K; Frank U
Antimicrob Agents Chemother; 2009 Oct; 53(10):4574-5. PubMed ID: 19770290
[No Abstract] [Full Text] [Related]
14. [i]Clostridioides difficile[/i] infection in patients with end stage renal disease. Is it preventable?
Lis Ł; Konieczny A; Żłobicka K; Witkiewicz W; Hruby Z
Przegl Epidemiol; 2020; 74(1):11-21. PubMed ID: 32500979
[TBL] [Abstract][Full Text] [Related]
15. Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015.
Krutova M; Matejkova J; Drevinek P; Kuijper EJ; Nyc O;
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2251-2258. PubMed ID: 28681203
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.
McFarland LV; Ozen M; Dinleyici EC; Goh S
World J Gastroenterol; 2016 Mar; 22(11):3078-104. PubMed ID: 27003987
[TBL] [Abstract][Full Text] [Related]
17. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
18. Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection.
AbdelKhalek A; Seleem MN
Int J Antimicrob Agents; 2020 Dec; 56(6):106188. PubMed ID: 33045352
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile drug pipeline: challenges in discovery and development of new agents.
Jarrad AM; Karoli T; Blaskovich MA; Lyras D; Cooper MA
J Med Chem; 2015 Jul; 58(13):5164-85. PubMed ID: 25760275
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.
Brown KA; Khanafer N; Daneman N; Fisman DN
Antimicrob Agents Chemother; 2013 May; 57(5):2326-32. PubMed ID: 23478961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
